HIV Knowledge, Perceived Risk and Gender as Modulators of Salivary HIV Rapid Testing in African Americans
Journal Title: HIV/AIDS Research and Treatment – Open Journal - Year 2018, Vol 0, Issue 1
Abstract
Background: Of more than 1.2 million people in the United States (US) living with HIV infection, almost 1 in 8 (12.8%) are unaware of their infection. The introduction of a rapid HIV test using a saliva sample in 2004 made immediate results possible in community-based settings. Despite use of salivary rapid testing (SRT) over the last ten years, not enough is known about barriers to and acceptability of SRT among African Americans (AAs). Purpose: The purpose of this study was to identify factors associated with SRT for HIV among AAs. Methods: A cross-sectional study was conducted with 329 AA men and women recruited from a sexually transmitted infection (STI) clinic. Results: Results of study showed that participants with higher AIDS knowledge (p less than 0.001) and problem-focused coping (p=0.015,p less than 0.001,p less than 0.04, respectively). Female participants with higher values of risky behavior tended to be more likely to participate in testing (p=0.001). Conclusions: The findings support the need to assess barriers and facilitators to testing decisions in order to increase testing rates. In particular, AIDS knowledge and either problem or emotional-focused coping and risky behaviors, based on gender may be important in making testing and care entry decisions.
Authors and Affiliations
Pamela Payne Foster
Keywords
Related Articles
- EP ID EP560737
- DOI 10.17140/HARTOJSE-1-105
- Views 112
- Downloads 0
Development of the M184V Mutation in HIV-1 Infection and Subsequent Treatment Outcomes
Objective: The purpose of this study was to describe the occurrence of the M184V mutation in a single clinic setting over a period of 10 years. We examined the combination Antiretroviral Therapy (cART) being taken at the...
Understanding Barriers to Linking High Risk Heterosexual African American Women to Care in the Upper South
As part of Centers for Disease Control and Prevention’s (CDC’s) HIV prevention strategic plan through 2010,1 4 national goals were identified to reduce by half the new HIV infections in the United States. One of the 4 go...
World AIDS Day: A Call to Action
December 1st is World AIDS Day (WAD); a time to raise awareness about the Human Immunodeficiency Virus (HIV) and Acquired Immune Deficiency Syndrome (AIDS) and reflect on the lives of those living with and affected by th...
A Rare Case of BCGiosis With Severe Combined Immunodeficiency
Background: Bacille Calmette-Guerin (BCG), a live attenuated vaccine, is safe and given to all neonates in endemic countries; however may rarely cause disseminated disease, especially in immuno-deficient individuals. Cas...
Determination on the Expression of Activated RANTES G 28 in HIV-1 Infection and in Co Infection with Hepatitis B Virus and Hepatitis C Virus and Its Effect on Leukocytes
Human Immunodeficiency Virus (HIV), coinfected with hepatitis B virus and hepatitis C virus challenges the immune system. Regulated on activation normal T cell expressed and secreted (RANTES) is one of the natural ligand...